Terms: = Skin cancer AND FEV, Pet-1, 54738, ENSG00000163497, PET-1, HSRNAFEV AND Treatment
4 results:
1. Efficacy and safety of rituximab therapy in patients with systemic sclerosis disease (SSc): systematic review and meta-analysis.
Moradzadeh M; Aghaei M; Mehrbakhsh Z; Arab-Bafrani Z; Abdollahi N
Clin Rheumatol; 2021 Oct; 40(10):3897-3918. PubMed ID: 33796953
[TBL] [Abstract] [Full Text] [Related]
2. Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review.
Sehatzadeh S
Ont Health Technol Assess Ser; 2012; 12(3):1-64. PubMed ID: 23074431
[TBL] [Abstract] [Full Text] [Related]
3. tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.
Wardley AM; Hiller L; Howard HC; Dunn JA; Bowman A; Coleman RE; Fernando IN; Ritchie DM; Earl HM; Poole CJ;
Br J Cancer; 2008 Aug; 99(4):597-603. PubMed ID: 18665163
[TBL] [Abstract] [Full Text] [Related]
4. Failure of sulfites to produce clinical responses in patients with systemic mastocytosis or recurrent anaphylaxis: results of a single-blind study.
Meggs WJ; Atkins FM; Wright R; Fishman M; Kaliner MA; Metcalfe DD
J Allergy Clin Immunol; 1985 Dec; 76(6):840-6. PubMed ID: 3905921
[TBL] [Abstract] [Full Text] [Related]
